Structure—Activity Relationships of Quinone and Acridone Photosystem II Inhibitors

Author(s):  
Wilfried Draber ◽  
Achim Trebst ◽  
Walter Oettmeier
1993 ◽  
Vol 48 (3-4) ◽  
pp. 163-167
Author(s):  
Koichi Yoneyama ◽  
Yoshihiro Nakajima ◽  
Masaru Ogasawara ◽  
Hitoshi Kuramochi ◽  
Makoto Konnai ◽  
...  

Abstract Through the studies on structure-activity relationships of 5-acyl-3-(1-aminoalkylidene)-4-hydroxy-2 H-pyran-2,6(3 H)-dione derivatives in photosystem II (PS II) inhibition, overall lipophilicity of the molecule was found to be a major determinant for the activity. In the substituted N -benzyl derivatives, not only the lipophilicity but also the electronic and steric characters of the substituents greatly affected the activity. Their mode of PS II inhibition seemed to be similar to that of DCMU , whereas pyran-enamine derivatives needed to be highly lipophilic to block the electron transport in thylakoid membranes, which in turn diminished the permeability through biomembranes.


1990 ◽  
Vol 45 (5) ◽  
pp. 317-321 ◽  
Author(s):  
Koichi Yoneyama ◽  
Makoto Konnai ◽  
Ichiro Honda ◽  
Shigeo Yoshida ◽  
Nobutaka Takahashi ◽  
...  

Studies on structure/activity relationships of phloroglucinol derivatives that had been designed based on the structures of grandinol and homograndinol. potent photosystem II (PS II) inhibitors in Eucalyptus grandis, revealed that two electron-withdrawing groups which differ by their electron-withdrawing power on a phloroglucinol nucleus were essential for activity. A larger difference in the electron-withdrawing power between the two groups enhanced the activity, and 3-nitro-phloroglucinecarboxamides and the corresponding thioamides were the most active ones when they had proper lipophilic side chains. Their binding domain seems to overlap with those of DCMU and atrazine, whereas they may approach to the site in a similar manner to that of phenol type inhibitors. Accordingly, the phloroglucinol derivatives represent a new type of PS II inhibitors.


1984 ◽  
Vol 32 (1) ◽  
pp. 133-144 ◽  
Author(s):  
Emil Kakkis ◽  
Vincent C. Palmire ◽  
Cynthia D. Strong ◽  
Walter Bertsch ◽  
Corwin Hansch ◽  
...  

Nano Letters ◽  
2019 ◽  
Vol 19 (3) ◽  
pp. 1844-1850 ◽  
Author(s):  
Xin Fang ◽  
Katarzyna P. Sokol ◽  
Nina Heidary ◽  
Tarek A. Kandiel ◽  
Jenny Z. Zhang ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Ales Imramovsky ◽  
Jan Kozic ◽  
Matus Pesko ◽  
Jirina Stolarikova ◽  
Jarmila Vinsova ◽  
...  

A series of twelve 2-[(E)-2-substituted-ethenyl]-1,3-benzoxazoles was designed. All the synthesized compounds were tested against three mycobacterial strains. The compounds were also evaluated for their ability to inhibit photosynthetic electron transport (PET) in spinach (Spinacia oleraceaL.) chloroplasts. 2-[(E)-2-(4-Methoxyphenyl)ethenyl]-1,3-benzoxazole, 2-[(E)-2-(2,3-dihydro-1-benzofuran-5-yl)ethenyl]-1,3-benzoxazole and 2-{(E)-2-[4-(methylsulfanyl)phenyl]ethenyl}-1,3-benzoxazole showed the highest activity againstM. tuberculosis,M. kansasii,andM. avium, and they demonstrated significantly higher activity againstM. aviumandM. kansasiithan isoniazid. The PET-inhibiting activity of the most activeortho-substituted compound 2-[(E)-2-(2-methoxyphenyl)ethenyl]-1,3-benzoxazole was IC50= 76.3 μmol/L, while the PET-inhibiting activity ofpara-substituted compounds was significantly lower. The site of inhibitory action of tested compounds is situated on the donor side of photosystem II. The structure-activity relationships are discussed.


1991 ◽  
Vol 41 (3) ◽  
pp. 288-295 ◽  
Author(s):  
Koichi Yoneyama ◽  
Yoshihiro Nakajima ◽  
Makoto Konnai ◽  
Hajime Iwamura ◽  
Tadao Asami ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document